Big Pharma
Developing pain medication with fewer side effects
Developing pain medication with fewer side effects SASKATOON – Pain relief is a critical issue in medicine, but effective pain management is often overlooked. Opiates like morphine and codeine provide many patients with relief: from the ache felt after mild surgery to chronic pain experienced by cancer patients. However, this type of medication can cause multiple side effects and can lead to physical dependency with long-term use. Improving pain medication would help millions of people to have a better quality of life. Dr. Ken Ng, a professor at the University of Windsor and adjunct professor at the University of Calgary...
New AI tool will predict patients at high risk for opioid use disorder and overdose
New AI tool will predict patients at high risk for opioid use disorder and overdose Wei-Hsuan “Jenny” Lo-Ciganic, Associate Professor, UF College of Pharmacy Newswise — University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose. The tool will use data from patients’ electronic medical records to guide clinicians in safely and effectively prescribing opioid medications. The project is supported by a five-year, $3.2 million grant from the National Institute on Drug Abuse, or NIDA, and aims to reduce the unprecedented rise in...
Merck Launches ColorWheel Flow Cytometry Antibodies
Merck Launches ColorWheel Flow Cytometry Antibodies and Dyes to Provide Flexibility in Flow Cytometry Workflows Flexibility to pair any antibody with any dye Less than 5 minutes of hands-on time for a simplified workflow vs. conjugation kits Lyophilized product for enhanced stability and ambient shipping Preservative-free presentation for sustainability and wider sample type compatibility Merck announced the launch of its new ColorWheel® flow cytometry portfolio, utilizing a proprietary technology optimized for flow cytometry that allows users to independently select antibodies and dyes for assembly in any desired combination. The output of these mix-and-matched antibodies and dyes is analogous...
Astronaut and physiologist Dr Jessica Meir visits UK
Astronaut and physiologist Dr Jessica Meir visits UK to inspire next generation of female scientists
Astronaut and physiologist Dr Jessica Meir visits UK to inspire next generation of female scientists PRESS RELEASE & INTERVIEW OPPORTUNITY: NASA ASTRONAUT VISITS UK TO INSPIRE NEXT GENERATION OF FEMALE SCIENTISTS Astronaut and physiologist Dr Jessica Meir, part of the first all-female spacewalk, visits UK to inspire next generation of female scientists. Physiologist and NASA astronaut Dr Jessica Meir made history in 2019 by being part of the historic first all-female spacewalk, and there’s a chance she may be the first woman on the moon. Dr Meir will be visiting the UK to give The Physiological Society’s 2021 President’s...
MākuSafe Launches Motion Explorer Aimed At Musculoskeletal Disorders
MākuSafe Launches Motion Explorer Aimed At Musculoskeletal Disorders (MSDs) and Repetitive Motion Injuries MākuSafe announced the launch of a game-changing new feature in its EHS analytics software today to help prevent musculoskeletal disorders (MSDs) and cumulative trauma injuries in industrial workers. MākuSafe's Motion Explorer Helps Prevent Musculoskeletal Disorders and Cumulative Trauma MSDs are the single largest category of workplace injuries and are responsible for almost 30 percent of all workers’ compensation costs, according to the Bureau of Labor Statistics (BLS). DES MOINES, Iowa (PRWEB) November 08, 2021 MākuSafe announced the launch of a game-changing new feature in its EHS analytics...